Reviewing Varex Imaging (VREX) and WaferGen Bio-systems (WGBS)
Varex Imaging (NASDAQ: VREX) and WaferGen Bio-systems (NASDAQ:WGBS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.
Earnings and Valuation
This table compares Varex Imaging and WaferGen Bio-systems’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Varex Imaging||$654.50 million||1.90||$115.80 million||N/A||N/A|
Varex Imaging has higher revenue and earnings than WaferGen Bio-systems.
This is a summary of recent ratings and price targets for Varex Imaging and WaferGen Bio-systems, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Varex Imaging currently has a consensus price target of $33.50, indicating a potential upside of 1.42%. Given Varex Imaging’s higher probable upside, research analysts clearly believe Varex Imaging is more favorable than WaferGen Bio-systems.
Insider & Institutional Ownership
91.7% of Varex Imaging shares are owned by institutional investors. Comparatively, 49.8% of WaferGen Bio-systems shares are owned by institutional investors. 5.8% of WaferGen Bio-systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
This table compares Varex Imaging and WaferGen Bio-systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Varex Imaging beats WaferGen Bio-systems on 7 of the 8 factors compared between the two stocks.
About Varex Imaging
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect. The Medical business segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, radiation therapy and computer-aided detection. The Industrial business segment designs, manufactures, sells and services products for use in security and industrial inspection applications, such as cargo screening at ports and borders and non-destructive examination in a range of applications.
About WaferGen Bio-systems
WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company’s ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company’s SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company’s SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with Analyst Ratings Network's FREE daily email newsletter.